Evolutionary tuning of rhodopsin-mediated light protection

Authors:

Abstract
Visual sensitivity introduces the inherent risk of blinding photodamage. Rhodopsin directly mediates this vulnerability, as activation drives excessive signaling via the Meta-II (MII) state, which subsequently releases the toxic, desensitizing agonist all- trans retinal (atRAL). In dim-light specialists, slow atRAL release is assumed to reflect extended MII signaling; however, this model ignores that arrestin quenches signaling in milliseconds and that apparent release reflects reversible atRAL rebinding. Here we reveal that extended post-bleach lifetimes— including an atRAL-driven shift toward non-signaling Meta-III (MIII)—evolved independently of intrinsic G-protein signaling to dually protect retinal cells against photochemical toxicity and shield neighboring receptors from agonist noise. Dim-light specialists whose rod-dense retinas experience daytime solar flux, such as megabats, possess an extremely cytoprotective rhodopsin that retains nearly 60% of atRAL at equilibrium by partitioning into MIII—validating long-standing predictions that MIII buffers retinoid toxicity while explaining why bat rhodopsin signals more weakly than faster-releasing human or bovine orthologs. To definitively uncouple sequestration from intrinsic signaling, we engineered an active-state-locked, signaling-null rhodopsin that achieves 100% atRAL sequestration and confers extreme cytoprotection in retinal cells. Mimicking partial bleaches with heterogeneous active and inactive receptor populations, co-incubation reveals that this signaling-null sink acts in trans to boost wild-type rhodopsin regeneration and signaling by shielding neighboring dark-state receptors from agonist interference. Lastly, while consensus human rhodopsin is non-protective, alleles restoring cytoprotective sequestration emerged in high-irradiance geographies, conferring a 38% reduced risk of blindness in modern populations. Our findings redefine rhodopsin as a tunable light buffer shaping adaptation and human disease. Significance Statement: Vision requires light-activated rhodopsin to release the reactive chromophore all-trans retinal (atRAL), which can accumulate to toxic levels and drive blinding macular degenerations. Across vertebrate evolution, slow atRAL release in dim-light animals has long been assumed to reflect a prolonged G-protein signaling state. Here we overturn this paradigm, revealing that slow retinal release instead reflects reversible atRAL sequestration into a non-signaling Meta-III state that acts as a “light buffer”. This sequestration dually protects retinal cells against acute atRAL toxicity and enhances visual sensitivity by shielding neighboring receptors from agonist noise. While consensus human rhodopsin lacks this protection, high-capacitance alleles emerged in high-irradiance geographies and reduce blindness risk by 38% in modern populations.